Characterization of cardiovascular diseases (CVD) in people with long duration Type 1 diabetes

长期 1 型糖尿病患者心血管疾病 (CVD) 的特征

基本信息

  • 批准号:
    10372462
  • 负责人:
  • 金额:
    $ 85.09万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-12-24 至 2025-11-30
  • 项目状态:
    未结题

项目摘要

Abstract Cardiovascular disease (CVD) is the major cause of mortality in Type 1 diabetes (T1D). Some CVD risk factors are shared between people with T1D and Type 2 diabetes (T2D). However, differences in dyslipidemia, severity of insulin resistance, disease onset, responses to glycemic control, and presence of autoimmunity suggest that the pathogenesis of CVD may differ between T1D and T2D. Diabetic nephropathy (DN) is a major risk factor for CVD in T1D; but while it occurs in 40% of those with T1D, CVD is still the major cause of mortality in those without DN. Autoimmunity may also contribute to CVD, since the risks of atherosclerosis are elevated in several autoimmune diseases. Understanding the pathogenesis of CVD in TID is hampered also by the lack of comparative pathological studies of coronary vessels of aging people with T1D versus T2D and non-diabetic subjects. Preliminary studies from the Medalist Study, a large cohort (n=1019) with >50 years of insulin-dependent T1D, showed that while only 13% have DN, 40% exhibited significant CVD history, which correlated with coronary artery calcium (CAC) scores by CT and myocardial dysfunction by cardiac MRI (CMR). While >90% of Medalists possess high-risk HLA alleles for classic autoimmune T1D, 8% also have known genes for monogenic diabetes. The Medalist biobank includes plasma/serum samples and postmortem organ specimens (hearts with coronary vessels, aortae, kidney, pancreases and others). Pilot studies in Medalists provide the first extensive characterizations of inflammatory and metabolomics profiles of T1D and their associations with CAC scores and CMR parameters, which may indicate differences with published data on T2D. Pilot morphological studies of Medalists’ coronary vessels clearly identified immune cell infiltrates, including CD3+ T-cells. The role of autoimmunity in exacerbating atherosclerosis is clearly demonstrated by studies using newly-created ApoE-/-/NOD mice with autoimmune diabetes closely mimicking T1D, which exhibited significantly more atherosclerotic plaques containing elevated subsets of pro-inflammatory T-cells and less regulatory T-cells than in non-diabetic ApoE-/-/CongNOD control mice. In this proposal, we aim to characterize CVD in T1D by clinical, biochemical, imaging, metabolomic and pathological studies, and their associations with autoimmunity, via comparative studies of the Medalist cohort with T2D, monogenic diabetes and non-diabetic subjects. Our specific aims are as follows: Sp. Aim 1: To characterize atherosclerosis and myocardial structure and function in type 1 diabetes of long duration (Joslin Medalist Study) by CVD history and imaging, presence of autoimmunity, beta cell function, inflammatory and metabolomics markers, metabolic control and microvascular diseases. Sp. Aim 2: To compare the plaque characteristics and composition of immune cells, including monocytes, macrophages, B-cells and T-cells (CD3+, CD4+ and CD8+ T cells) and subtypes of T-cells (Treg, Tfh, Th1 and Th17) in the atherosclerotic plaques of the coronary vessels and peripheral arteries from patients with T1D, T2D, monogenic diabetes and no DM.
摘要 心血管疾病(CVD)是1型糖尿病(T1 D)死亡的主要原因。一些CVD危险因素 2型糖尿病(T2 D)的发病率是多少?然而,血脂异常的差异, 胰岛素抵抗的严重程度、疾病发作、对血糖控制的反应和自身免疫的存在 提示CVD的发病机制在T1 D和T2 D之间可能不同。糖尿病肾病(DN)是一种严重的 T1 D中CVD的危险因素;但尽管它发生在40%的T1 D患者中,CVD仍然是T1 D的主要原因。 无DN的患者死亡率。自身免疫也可能导致CVD,因为动脉粥样硬化的风险是 在几种自身免疫性疾病中升高。理解TID中CVD的发病机制也受到以下因素的阻碍: 缺乏T1 D与T2 D老年人冠状动脉血管的比较病理学研究, 非糖尿病患者。来自Medalist研究的初步研究,一个大型队列(n=1019), 胰岛素依赖性T1 D显示,虽然只有13%患有DN,但40%表现出严重的CVD病史,这 与CT冠状动脉钙化(CAC)评分和心脏MRI心肌功能不全相关 (CMR)。虽然>90%的奖牌获得者具有典型自身免疫性T1 D的高风险HLA等位基因,但8%的人也具有高风险HLA等位基因。 单基因糖尿病的已知基因Medalist生物库包括血浆/血清样本和尸检样本。 器官标本(带冠状血管的心脏、心脏、肾脏、胰腺等)。试点研究, Medalists提供了T1 D的炎症和代谢组学特征的第一个广泛特征, 它们与CAC评分和CMR参数的相关性,这可能表明与已发表数据的差异 关于T2 D对奖牌获得者冠状血管的初步形态学研究清楚地发现了免疫细胞浸润, 包括CD 3 + T细胞。自身免疫在动脉粥样硬化恶化中的作用已被清楚地证实, 使用新创建的ApoE-/-/NOD小鼠进行的研究, 显示出显著更多的动脉粥样硬化斑块,其中含有升高的促炎性T细胞亚群 和比非糖尿病ApoE-/-/CongNOD对照小鼠更少的调节性T细胞。在本建议中,我们的目标是 通过临床、生化、成像、代谢组学和病理学研究表征T1 D中的CVD, 通过对T2 D、单基因糖尿病的Medalist队列的比较研究, 和非糖尿病受试者。我们的具体目标如下:Sp.目标1:表征动脉粥样硬化和 根据CVD病史对长期1型糖尿病患者心肌结构和功能的研究(Joslin Medalist研究) 和成像,自身免疫的存在,β细胞功能,炎症和代谢组学标志物,代谢 控制和微血管疾病。目的2:比较两组患者的菌斑特征和组成, 免疫细胞,包括单核细胞、巨噬细胞、B细胞和T细胞(CD 3+、CD 4+和CD 8 + T细胞),以及 冠状动脉粥样硬化斑块中的T细胞亚型(Treg、Tfh、Th 1和Th 17), T1 D、T2 D、单基因糖尿病和非DM患者的外周动脉。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

GEORGE L KING其他文献

GEORGE L KING的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('GEORGE L KING', 18)}}的其他基金

A pilot clinical trial to assess feasibility, facilitators and barriers of continuous glucose monitoring in Asian Americans with type 2 diabetes
一项试点临床试验,旨在评估患有 2 型糖尿病的亚裔美国人进行连续血糖监测的可行性、促进因素和障碍
  • 批准号:
    10511276
  • 财政年份:
    2022
  • 资助金额:
    $ 85.09万
  • 项目类别:
A pilot clinical trial to assess feasibility, facilitators and barriers of continuous glucose monitoring in Asian Americans with type 2 diabetes
一项试点临床试验,旨在评估患有 2 型糖尿病的亚裔美国人进行连续血糖监测的可行性、促进因素和障碍
  • 批准号:
    10709518
  • 财政年份:
    2022
  • 资助金额:
    $ 85.09万
  • 项目类别:
Characterization of cardiovascular diseases (CVD) in people with long duration Type 1 diabetes
长期 1 型糖尿病患者心血管疾病 (CVD) 的特征
  • 批准号:
    10543994
  • 财政年份:
    2021
  • 资助金额:
    $ 85.09万
  • 项目类别:
Pyruvate kinase M2 levels and activation as protective factors for diabetic nephropathy
丙酮酸激酶 M2 水平和激活作为糖尿病肾病的保护因素
  • 批准号:
    9235747
  • 财政年份:
    2016
  • 资助金额:
    $ 85.09万
  • 项目类别:
Characterization of Retinoid-Binding Protein 3 (RBP3): A Protective Factor Against Diabetic Retinopathy Identified in People with Extreme Diabetes Duration
类视黄醇结合蛋白 3 (RBP3) 的表征:在患有极度糖尿病病程的人群中发现的针对糖尿病视网膜病变的保护因子
  • 批准号:
    10320034
  • 财政年份:
    2016
  • 资助金额:
    $ 85.09万
  • 项目类别:
Characterization of Retinoid-Binding Protein 3 (RBP3): A Protective Factor Against Diabetic Retinopathy Identified in People with Extreme Diabetes Duration
类视黄醇结合蛋白 3 (RBP3) 的表征:在患有极度糖尿病病程的人群中发现的针对糖尿病视网膜病变的保护因子
  • 批准号:
    10543746
  • 财政年份:
    2016
  • 资助金额:
    $ 85.09万
  • 项目类别:
Identification of Retinoid-Binding Protein 3 (RBP3): A Protective Factor against Diabetic Retinopathy Using Retina from People with Extreme Duration of Diabetes
类维生素A结合蛋白3 (RBP3)的鉴定:利用糖尿病病程极长的人的视网膜来鉴定糖尿病视网膜病变的保护因子
  • 批准号:
    9006846
  • 财政年份:
    2016
  • 资助金额:
    $ 85.09万
  • 项目类别:
Validation of Potential Protective Factors from Diabetic Complications
验证糖尿病并发症的潜在保护因素
  • 批准号:
    8922182
  • 财政年份:
    2011
  • 资助金额:
    $ 85.09万
  • 项目类别:
Validation of Potential Protective Factors from Diabetic Complications
验证糖尿病并发症的潜在保护因素
  • 批准号:
    8241364
  • 财政年份:
    2011
  • 资助金额:
    $ 85.09万
  • 项目类别:
Protective Factors Against the Development of Microvascular Complications
防止微血管并发症发生的保护因素
  • 批准号:
    8150968
  • 财政年份:
    2010
  • 资助金额:
    $ 85.09万
  • 项目类别:

相似海外基金

Interplay between Aging and Tubulin Posttranslational Modifications
衰老与微管蛋白翻译后修饰之间的相互作用
  • 批准号:
    24K18114
  • 财政年份:
    2024
  • 资助金额:
    $ 85.09万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
The Canadian Brain Health and Cognitive Impairment in Aging Knowledge Mobilization Hub: Sharing Stories of Research
加拿大大脑健康和老龄化认知障碍知识动员中心:分享研究故事
  • 批准号:
    498288
  • 财政年份:
    2024
  • 资助金额:
    $ 85.09万
  • 项目类别:
    Operating Grants
EMNANDI: Advanced Characterisation and Aging of Compostable Bioplastics for Automotive Applications
EMNANDI:汽车应用可堆肥生物塑料的高级表征和老化
  • 批准号:
    10089306
  • 财政年份:
    2024
  • 资助金额:
    $ 85.09万
  • 项目类别:
    Collaborative R&D
Baycrest Academy for Research and Education Summer Program in Aging (SPA): Strengthening research competencies, cultivating empathy, building interprofessional networks and skills, and fostering innovation among the next generation of healthcare workers t
Baycrest Academy for Research and Education Summer Program in Aging (SPA):加强研究能力,培养同理心,建立跨专业网络和技能,并促进下一代医疗保健工作者的创新
  • 批准号:
    498310
  • 财政年份:
    2024
  • 资助金额:
    $ 85.09万
  • 项目类别:
    Operating Grants
関節リウマチ患者のSuccessful Agingに向けたフレイル予防対策の構築
类风湿性关节炎患者成功老龄化的衰弱预防措施的建立
  • 批准号:
    23K20339
  • 财政年份:
    2024
  • 资助金额:
    $ 85.09万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Life course pathways in healthy aging and wellbeing
健康老龄化和福祉的生命历程路径
  • 批准号:
    2740736
  • 财政年份:
    2024
  • 资助金额:
    $ 85.09万
  • 项目类别:
    Studentship
I-Corps: Aging in Place with Artificial Intelligence-Powered Augmented Reality
I-Corps:利用人工智能驱动的增强现实实现原地老龄化
  • 批准号:
    2406592
  • 财政年份:
    2024
  • 资助金额:
    $ 85.09万
  • 项目类别:
    Standard Grant
NSF PRFB FY 2023: Connecting physiological and cellular aging to individual quality in a long-lived free-living mammal.
NSF PRFB 2023 财年:将生理和细胞衰老与长寿自由生活哺乳动物的个体质量联系起来。
  • 批准号:
    2305890
  • 财政年份:
    2024
  • 资助金额:
    $ 85.09万
  • 项目类别:
    Fellowship Award
虚弱高齢者のSuccessful Agingを支える地域課題分析指標と手法の確立
建立区域问题分析指标和方法,支持体弱老年人成功老龄化
  • 批准号:
    23K20355
  • 财政年份:
    2024
  • 资助金额:
    $ 85.09万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
「ケア期間」に着目したbiological aging指標の開発
开发聚焦“护理期”的生物衰老指数
  • 批准号:
    23K24782
  • 财政年份:
    2024
  • 资助金额:
    $ 85.09万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了